Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Chronic Bowel Disorders: Introduction

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Programmable Surface Catalyzed Heterogeneous Nucleation Enables "Double-Cable" Light-Harvesting Supramolecular Polymers.

Journal of the American Chemical Society·2026

Same author

Evolving Concepts of Treatment Targets for Primary Biliary Cholangitis: A Global Perspective.

The American journal of gastroenterology·2026

Same author

Tunable TriPcides suppress virulence factor secretion during <i>Staphylococcus aureus</i> infection and kill dormant cells.

Science advances·2026

Same author

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Alimentary pharmacology & therapeutics·2026

Same author

Author Response to "Comment on Prediagnosis Alkaline Phosphatase and Antimitochondrial Antibody Positivity Vary by Race/Ethnicity Among Patients With Primary Biliary Cholangitis".

Journal of gastroenterology and hepatology·2026

Same author

Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies.

Hepatology communications·2026

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Primary Sclerosing Cholangitis: Multiple Phenotypes, Multiple Approaches.

Souvik Sarkar¹, Christopher L Bowlus¹

¹Division of Gastroenterology and Hepatology, University of California Davis School of Medicine, 4150 V Street, PSSB 3500, Sacramento, CA 95817, USA.

Clinics in Liver Disease

|November 24, 2015

Summary

This summary is machine-generated.

Primary sclerosing cholangitis (PSC) is a complex inflammatory disease often linked with inflammatory bowel diseases. Research is revealing distinct patient subphenotypes and improving our understanding for potential new therapeutics.

Keywords:

Autoimmune hepatitis Diagnosis IgG4-related sclerosing cholangitis Primary sclerosing cholangitis Treatment

More Related Videos

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Related Experiment Videos

Last Updated: Mar 29, 2026

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology

Published on: March 14, 2020

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Generation and Quantitative Characterization of Functional and Polarized Biliary Epithelial Cysts

Published on: May 16, 2020

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

Area of Science:

Hepatology and Gastroenterology
Autoimmune and Inflammatory Diseases

Background:

Primary sclerosing cholangitis (PSC) is an idiopathic, chronic inflammatory liver disease.
PSC is frequently diagnosed alongside inflammatory bowel diseases (IBD).
Patient heterogeneity is observed across different demographics, including pediatric, nonwhite, and female populations.

Purpose of the Study:

To explore the heterogeneity of Primary sclerosing cholangitis.
To identify distinguishing features in pediatric, nonwhite, and female PSC patients.
To understand the variable natural history and clinical outcomes of PSC.

Main Methods:

Review of existing literature and patient data.
Analysis of demographic factors influencing PSC presentation.
Examination of disease progression and associated complications.

Main Results:

PSC exhibits significant heterogeneity with distinct subphenotypes.
Pediatric, nonwhite, and female PSC patients display unique clinical characteristics.
PSC natural history is variable, with potential complications including bacterial cholangitis, cholangiocarcinoma, and colorectal adenocarcinoma.

Conclusions:

Current treatments like bile acid therapy and immunosuppression have shown limited efficacy.
Increased international collaboration enhances understanding of PSC's genetic structure and heterogeneity.
Further research into PSC subphenotypes may lead to more effective therapeutic strategies.